Monitoring contaminants of emerging concern from tertiary wastewater treatment plants using passive sampling modelled...

The Lake Simcoe watershed in Ontario, Canada is an important recreational area and a recharge zone for groundwater resources. Lake Simcoe is a relatively shallow lotic system that has been impacted by urban development, recreation, industry and agriculture. As part of a watershed management plan, six wastewater treatment plants (WWTPs) located in this catchment basin were selected to measure the inputs of contaminants of emerging concern (CECs) of wastewater origin. These WWTPs were recently upgraded to tertiary treatment for phosphorus removal. Polar organic chemical integrative samplers (POCIS) and semipermeable membrane devices (SPMDs) were used to monitor for hydrophilic and hydrophobic CECs, respectively, in treated and untreated wastewater. The passive samplers were calibrated with performance reference compounds (PRCs) by measuring the loss of deuterated beta blocker drugs spiked into POCIS and the loss of PCB congeners spiked into SPMDs over the course of 14-day deployment periods. From the PRC data, field sampling rates of CECs were determined and applied to estimate time-weighted average (TWA) concentrations and mass loadings in mg/day/1000 members of the population serviced. In treated wastewater, TWA concentrations of an antibiotic, sulfamethoxazole, the prescription drugs, carbamazepine, naproxen and gemfibrozil, and the non-prescription drug, ibuprofen, were estimated to be in the low (<18 ng/L) range. The artificial sweeteners, sucralose and acesulfame, were particularly useful chemical tracers, with estimated TWA concentrations in treated wastewater ranging from 128 to 213 ng/L and 4 to 33 ng/L, respectively. The steroid hormones were detected only rarely in treated wastewater. Triclosan, triclocarban and the synthetic musks, HHCB and AHTN, were removed efficiently (>77 %), possibly because of the tertiary treatment technologies. Therefore, the mass loadings for these personal care products were all <5 mg/day/1000 people. Overall, this study indicates that tertiary treatment technologies designed for phosphorus removal do not entirely remove the target CECs.